WDC stock is riding a four-day winning streak, gaining nearly 40% over the period and bucking the broader market weakness.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
The largest indexed ETFs are going to vary in their SpaceX (SPCX) exposure, following the stock’s IPO completed on June 12. Nasdaq and FTSE Russell decided to fast-track the inclusion of mega-cap IPOs in their indices, while S&P DJI opted not to change its methodology, explains Aniket Ullal, VP, ETF Data & Analytics at CFRA Research.
Four insiders, including the company’s Chief Administrative and Legal Officer and three directors, purchased more than 21,761 shares of Fiserv in the open market.
While Principal Financial Group has outperformed its sector peers recently, analysts remain cautious about the stock’s prospects.
AI infrastructure spending, memory chip demand, and consolidation across the entertainment industry drew investors’ interest.
(Bloomberg) -- A startup backed by former Google Chief Executive Officer Eric Schmidt unveiled an industrial robot powered by artificial intelligence, as investors pile into the emerging field of humanoids. Most Read from BloombergRead the 14-Point Draft Memorandum Between the US and IranIran’s Deputy Foreign Minister Confirms Deal Reached With USNetanyahu Pays a Political Price for Trump’s Iran DealUS Set to Offer Iran Broad Financial Gains in Peace DealModi Warns of ‘Shortage of Trust’ Ahead o
With Cisco Systems stock on many investors' watchlists, the key question is whether the current share price fairly reflects what the company may be worth over the long run. The stock most recently closed at US$119.57, with returns of 57.2% year to date and 87.2% over the past year, while the return over the last 7 days declined 0.7% and the return over the last 30 days was 1.2%. These moves can change how investors think about both upside potential and risk. Recent news coverage has focused...
Pfizer and SINOPHARM have entered into a new partnership to promote antifungal drug Diflucan in China. The collaboration also includes plans to work together on future Pfizer product launches in the Chinese market. The agreement focuses on supply chain optimization, resource integration, and improving commercial execution across China. Pfizer (NYSE:PFE) is using this new agreement with SINOPHARM to deepen its presence in one of the world’s most important pharmaceutical markets. With the...
In recent weeks, Shopify’s board expanded its share repurchase authorization to US$5.00 billion and held its 2026 annual meeting, where all director nominees were elected, auditors were reappointed, and shareholders endorsed the company’s executive compensation approach while rejecting a proposed artificial intelligence policy. At the same time, Shopify has been pushing deeper into AI-driven commerce and integrations, with merchants seeing very large growth in AI-sourced orders that convert...
CoreWeave Inc. (NASDAQ:CRWV) is one of the 10 Stocks With Standout Gains. CoreWeave rallied for a fourth straight session on Tuesday, jumping 9.67 percent to close at $117.03 apiece, as investor optimism was fueled by its looming inclusion in Nasdaq’s 100 largest non-financial companies. In an update late last week, CoreWeave Inc. (NASDAQ:CRWV) said that […]
Roblox Corp. (NYSE:RBLX) is one of the 10 Stocks With Standout Gains. Roblox rallied for a second day on Tuesday, surging 8.06 percent to close at $49.34 apiece, as investors took heart from its launch of two new accounts designed for increased protection, which are designed to evolve as children grow. In an update on […]
Eos Energy Enterprises Inc. (NASDAQ:EOSE) is one of the 10 Stocks With Standout Gains. Eos Energy rallied for a second day on Tuesday, climbing 6.74 percent to close at $6.81 apiece, as investors cheered the official start of production at its new facility in Pennsylvania. In an updated report, Eos Energy Enterprises Inc. (NASDAQ:EOSE) said […]
Moderna Inc. (NASDAQ:MRNA) is one of the 10 Stocks With Standout Gains. Moderna extended its winning streak to a fourth consecutive day on Tuesday, surging 6.27 percent to close at $55.40 apiece, as investors digested the looming launch of three new vaccines over the next two years. In a statement on the same day, Moderna […]
Coupang Inc. (NYSE:CPNG) is one of the 10 Stocks With Standout Gains. Coupang saw its share prices jump by 5.25 percent on Tuesday to close at $18.03 apiece, as investors traded while awaiting updates on its appeal in relation to a $410 million penalty imposed by South Korea’s Personal Information Protection Commission over a data […]
The launch window opens June 17 at 2:39 a.m. EDT, with ASTS confirming that the satellites are fully encapsulated and secured inside Falcon 9 ahead of liftoff.
Morningstar cut its fair value estimate to $62 from $63 after the Cursor acquisition, implying a 69% downside from current levels.
Before the stock took off, the company's overall growth looked sluggish, but management was explicitly forecasting a boom in its most important AI-related businesses.
SpaceX stock has been red hot following its IPO last week.
Both stocks have soared, but the two chipmakers are built very differently.
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 9.1% in the afternoon session after investors positioned ahead of a pivotal FDA advisory committee review for its mRNA seasonal flu vaccine.
In early June 2026, Palantir Technologies detailed fresh AI partnerships and customer deployments at its AIPCon 10 event, while shareholders rejected several activist proposals on human rights, political spending disclosure, and due‑diligence reporting at the company’s annual meeting. Together with new multi‑year collaborations in construction, insurance, and legal services, these governance votes highlight how Palantir’s rapid AI adoption is unfolding alongside unresolved concerns about...
While SpaceX continues its stellar post-IPO debut performance, investors should also keep another IPO on their radar.

<body><p>STORY: Wall Street's main indexes ended mixed on Tuesday, with the Dow gaining just under two-thirds of a percent to notch its second straight record-high close... while the S&P 500 shed more than half a percent and the Nasdaq dropped more than one percent.</p><p>Shares of Elon Musk's SpaceX ended nearly 5% higher, paring earlier gains. For much of the session, the rocket and AI company's value was above that of Amazon, and it briefly surpassed Microsoft's valuation, as retail investors continued to pour into the stock after its record-breaking IPO.</p><p>But Amol Dhargalkar, chairman and managing partner at Chatham Financial, warned of several risks that could trigger volatility for SpaceX and other AI-related stocks.</p><p>"I think that's a really difficult position to be in as a retail investor, especially when you consider the fact that there is a lot of risk, not just in the business model, but these are names where the cash flows are likely far into the future. And we are not in a period of 0% or negative interest rates or even declining interest rates at this point. </p><p>There's a lot of question as to whether interest rates will continue to be flat or will they go up. And that can certainly be a meaningful drag on valuations of high growth companies, especially where that growth is out far into the future."</p><p>Investors will look for clues on where interest rates are headed when the Federal Reserve concludes its latest two-day policy meeting on Wednesday, with Kevin Warsh holding his first press conference as Fed chair.</p><p>Other stocks on the move included shares of Olin, which sank nearly 6% after the chemical producer said it would acquire Huntsman in an all-stock deal valued at more than $2.4 billion. Huntsman shares also fell as the offer stood at a discount to the stock's recent price.</p><p>:: Yum Brands</p><p>And shares of Yum Brands rose after the fast-food company said it would sell its Pizza Hut chain for $2.7 billion, against a backdrop of softer consumer spending across the fast-food industry.</p></body>
The U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet on June 18 to assess the benefit-risk profile of mFlusiva.
Since December 2025, Boise Cascade has been in a holding pattern, posting a small loss of 4.9% while floating around $72.09. The stock also fell short of the S&P 500’s 9.3% gain during that period.
Wolfe Research upgrades Palantir stock to “Peer Perform.” Here’s why the firm’s analysts turned bullish on PLTR shares for the remainder of 2026.
Over the past six months, ESAB’s shares (currently trading at $97) have posted a disappointing 15.2% loss, well below the S&P 500’s 9.3% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Procter & Gamble (NYSE:PG) is the household name every retirement portfolio reaches for when markets get choppy, and its $350.4 billion market cap makes it the default consumer defensive trade on every desk. The internals tell a different story. The Crowded Trade Is Quietly Cracking P&G beat its most recent quarter, but the internals are ... Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today
The move builds on an already historic run. SpaceX priced its IPO at $135 per share on June 12, 2026, in what was the largest public offering in history, raising $75 billion initially. Underwriters exercised their greenshoe option on June 15, lifting total proceeds to $85.7 billion. Tuesday's close puts SPCX up roughly 50% from its IPO price in just four trading sessions, a pace that has rattled even the most seasoned market observers.
SPCX stock added 5% on Tuesday, surpassing both Microsoft and Amazon in market cap at one point during the session.